Mitra Angkasa Sejahtera Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Mitra Angkasa Sejahtera Tbk. trades at Rp29 (market cap 134.41B, 984.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.3× Mitra Angkasa Sejahtera Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.44M versus 984.9K). Which is the better fit depends on your goals.
| BAUT | LABS | |
|---|---|---|
Market Cap | 134.41B | 584.6B |
Volume | 984.9K | 1.44M |
Lot | 9.85K | 14.4K |
Turnover | 28.4M | 209.72M |
Average Price | 28.84 | 145.64 |
Value | 28.4M | 209.72M |
Indicative Equilibrium Price | 29 | 146 |
Indicative Equilibrium Volume | 2.57K | 753 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitra Angkasa Sejahtera Tbk (“the Company”) is established based on Deed of Establishment No. 63 dated November 19, 2012 made by Doktorandus Wijanto Suwongso, S.H., Notary in Jakarta. The Company started its commercial operations in 2016.
Read more on BAUT →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →